Other OTC - Delayed Quote USD

Shandong Weigao Group Medical Polymer Company Limited (SHWGY)

2.4450 0.0000 (0.00%)
At close: April 16 at 2:28 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jing Long Executive Chairman of the Board & Compliance Officer 278.49k -- 1975
Mr. Rinan Cong CEO & Executive Director 220.53k -- 1981
Mr. Junqiang Lu Executive Director 126.69k -- 1974
Mr. Xue Feng Wu Chief Financial Officer -- -- 1978
Ms. Miu Ling Wong ACIS, FCIS, FCS Company Secretary -- -- 1969

Shandong Weigao Group Medical Polymer Company Limited

Torch Hi-Tech Science Park
1 Weigao Road No.18 Xingshan Road
Weihai, 264210
China
86 63 1562 1999 https://www.weigaogroup.com
Sector: 
Healthcare
Full Time Employees: 
12,519

Description

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, specialized single-use clinical collection kits, digital products for clinical care, digestive nutrition, and primary care products; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, open and minimally invasive surgical equipment, wound healing dressings, wound suture, wound cleaning, and nonvascular catheter supporting extracorporeal devices. It also provides blood collection, irradiation, storage, separation, and sterilization products; blood collection and blood glucose testing devices; trauma, spinal implant, artificial joints, sports injury, soft tissue repair, reconstruction implant, orthopedic filling, and orthopedic related surgical tools; tumor intervention, vascular intervention, and interventional imaging; and prefilled syringes and pre-filled flush syringes. In addition, the company engages in the manufacturing of implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and X-ray based irradiation machines. Further, it is involved in the finance leasing and factoring business; provision of asset management, enterprise consulting, enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Corporate Governance

Shandong Weigao Group Medical Polymer Company Limited’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 7; Board: 5; Shareholder Rights: 10; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Dec 08, 2023
    Dividend Date
  • Oct 26, 2023
    Ex-Dividend Date

Upcoming Events

Related Tickers